{
    "code": 0,
    "data": [
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper intimation regarding Special Window for re-lodgement of transfer requests of Physical shares",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=84e7b89f-eae6-4c71-ad3a-53f34529ee0b.pdf",
            "news_date": "2026-02-10 16:32:46"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "General Updates",
            "news_body": "Intimation of executed share subscription and shareholders agreement (SSSHA) and Captive Power Agreement (CPA) for procuring electricity from First Energy 11 Private Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d1c654a-abd4-4d02-ab6c-6a966f1ba7e5.pdf",
            "news_date": "2026-01-30 18:03:46"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8253538-7dbc-4677-a44e-0bb877d1b8a3.pdf",
            "news_date": "2026-01-28 15:32:05"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimations of Revised Investor presentation",
            "news_id": "d637fab8-2e86-454c-8049-498afefbe841",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba8526fd-67e9-4a90-b801-0efbe3504f4f.pdf",
            "news_date": "2026-01-28 12:02:30",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Intimations of Revised Investor presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ba8526fd-67e9-4a90-b801-0efbe3504f4f.pdf",
            "news_date": "2026-01-28 12:02:30"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation in respect to the Board Meeting held on January 27 2026",
            "news_id": "8d3ddb55-7fe5-4a5d-b446-671a2e5e77fc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3249c429-2e6c-4f5d-af4c-2501f62a0704.pdf",
            "news_date": "2026-01-27 20:32:55",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation in respect to the Board Meeting held on January 27 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3249c429-2e6c-4f5d-af4c-2501f62a0704.pdf",
            "news_date": "2026-01-27 20:32:55"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release in respect to the Board Meeting held on January 27 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=809657c4-43cb-4bb7-b7c8-104477dfa7b9.pdf",
            "news_date": "2026-01-27 19:54:21"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result Quarter Ended On December 31 2025",
            "news_body": "Financial Result Quarter ended on December 31 2025",
            "news_id": "0958d450-a75e-4220-ad57-325bda7fdd11",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfd8c930-cd44-45ff-a474-e14a05631c0c.pdf",
            "news_date": "2026-01-27 19:51:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Result Quarter Ended On December 31 2025",
            "news_body": "Financial Result Quarter ended on December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cfd8c930-cd44-45ff-a474-e14a05631c0c.pdf",
            "news_date": "2026-01-27 19:51:27"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On January 27 2026.",
            "news_body": "Outcome of Board Meeting held on January 27 2026",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5e7e484-74af-4277-bc5a-313d11448e3c.pdf",
            "news_date": "2026-01-27 19:36:37"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Intimation Of Board Meeting",
            "news_body": "RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2026 inter alia to consider and approve Pursuant to the provisions of Regulation 29 and 50 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Tuesday January 27 2026 inter-alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e3d58a0-02de-46ec-99d4-fa17513304d6.pdf",
            "news_date": "2026-01-20 18:38:04"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Reg. 74(5) of SEBI (DP) Regulation 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0396698e-5526-475f-8848-e8fa8db5d54c.pdf",
            "news_date": "2026-01-09 18:34:35"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e96f45a3-e88f-4979-a147-c3a159297c0e.pdf",
            "news_date": "2026-01-07 19:09:44"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority Maharashtra",
            "news_body": "Disclosure under Regulation 30 of SEBI LODR 2015 for Details of order received from GST Authority Maharashtra.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55f0915d-a1f3-4f11-9803-b015ff92fa28.pdf",
            "news_date": "2025-12-29 16:47:17"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": " Incorporation Of A Wholly Owned Subsidiary.",
            "news_body": "Company has incorporated a Wholly Owned Subsidiary Company in name and style \"RPG Active Pharma Limited\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ea7cdb2-9fcc-4b7f-a167-62efd83f5e8b.pdf",
            "news_date": "2025-12-24 22:09:26"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading window for Quarter and nine months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab2b2754-9b20-45db-b4a1-438bdfc257e3.pdf",
            "news_date": "2025-12-24 17:06:49"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30(5)",
            "news_body": "Disclosure under regulation 30(5) is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=884d9498-5b2a-4d29-a8a2-c6dac6be6778.pdf",
            "news_date": "2025-12-15 15:41:23"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation With Respect To Proposed Incorporation Of A Wholly Owned Subsidiary Is Enclosed Herewith",
            "news_body": "Intimation with respect to prosed incorporation of a wholly owned subsidiary is enclosed herewith",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9f60144-dda1-493f-aff0-d67d0afadbe0.pdf",
            "news_date": "2025-12-15 15:36:20"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "intimation on appointment of Mr. Amol Lone as Chief Financial Officer of the Company is enclosed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea174e3d-9fff-404c-b2f2-8818978eff94.pdf",
            "news_date": "2025-12-15 15:31:33"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Outcome Of The Board Meeting Held On December 15 2025",
            "news_body": "Outcome of Board meeting held on December 15 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b2b0c02-7cb3-4db8-9000-9ddcbb7c0277.pdf",
            "news_date": "2025-12-15 15:26:18"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of SEBI LODR 2015 For Details Of Order Received From GST Authority Gujarat.",
            "news_body": "Disclosure under regulation 30 of SEBI LODR 2015 for details of order received from GST Authority Gujarat",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65dc7754-d09e-4c3a-b3aa-fd964de65400.pdf",
            "news_date": "2025-11-28 11:12:20"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of reminder notice issued to shareholder in respect to Special Window for re-lodgement of Physical shares Transfer requests",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34d854a2-5173-444f-8ee7-1606b02eddb5.pdf",
            "news_date": "2025-11-15 12:19:36"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The company has informed about Transcript of Earnings call held on 17th October 2025.",
            "news_id": "5523e4ed-0e21-49fa-9dfe-9d714786f113",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01fb77ab-399e-4201-8f6d-115fe7c69397.pdf",
            "news_date": "2025-10-24 19:24:56",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The company has informed about Transcript of Earnings call held on 17th October 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01fb77ab-399e-4201-8f6d-115fe7c69397.pdf",
            "news_date": "2025-10-24 19:24:56"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The Company has informed about the recording of Earnings Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2a95ec4-cacb-4898-97b0-2b3ab99eaa98.pdf",
            "news_date": "2025-10-18 14:43:21"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The Company has informed about the recording of Earnings Call.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4d732975-7a3e-4421-b696-dad7884b809f.pdf",
            "news_date": "2025-10-18 14:41:40"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5267ce92-b0fb-48ff-bb18-1eb227fecbe6.pdf",
            "news_date": "2025-10-18 14:21:05"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71a449a9-42ac-400a-80ac-6ed607acd029.pdf",
            "news_date": "2025-10-17 20:32:14"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Resignation of Chief Financial Officer (CFO)",
            "caption": "Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)",
            "news_body": "Change in Key Managerial Personnel",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2825697-7b8a-4408-95e0-02891c97175f.pdf",
            "news_date": "2025-10-17 18:27:52"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation",
            "news_id": "ed71c479-3041-4ccd-82d1-83287048713d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ac5e3d-7c6e-41ce-98ae-80cf42a5113a.pdf",
            "news_date": "2025-10-17 18:08:50",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71ac5e3d-7c6e-41ce-98ae-80cf42a5113a.pdf",
            "news_date": "2025-10-17 18:08:50"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "RPG Life Sciences Limited Has Submitted To The Exchange The Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Financial Result",
            "news_id": "077e01e2-d664-454d-bd14-0532969ae7b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d37dd0-303b-461b-8ac0-1ddb3fbc0dde.pdf",
            "news_date": "2025-10-17 18:00:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "RPG Life Sciences Limited Has Submitted To The Exchange The Financial Results For The Quarter And Half Year Ended September 30 2025.",
            "news_body": "Financial Result",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2d37dd0-303b-461b-8ac0-1ddb3fbc0dde.pdf",
            "news_date": "2025-10-17 18:00:27"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On October 17 2025",
            "news_body": "Outcome of Board Meeting held on October 17 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1475374e-ead9-4948-aafd-e461423549c3.pdf",
            "news_date": "2025-10-17 17:52:42"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of Earning call for Q2 FY26 scheduled on October 17 2025 .",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8571655-23b1-432b-a51b-d83b4f3f5661.pdf",
            "news_date": "2025-10-14 13:39:32"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation for Q2FY26 Results Earnings Call Scheduled on October 17 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb01a3a1-7b0e-4f4a-93f2-5e9a0fdd2c55.pdf",
            "news_date": "2025-10-13 18:56:59"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Company has informed about Reg 74(5) of SEBI (DP) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f0fbfa7-b805-41c0-bd86-0b72c2a53edc.pdf",
            "news_date": "2025-10-10 17:06:03"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for  Board Meeting Intimation For RPG Life Sciences Limited To Consider And Approve Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 inter alia to consider and approve RPG Life Sciences Limited informed that the meeting of the Board of Directors of the Company is scheduled on 17/10/2025 to consider and approve Unaudited Financial Results for the quarter and half year ended September 30 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44e650aa-2f3d-4cda-a3fe-ed81ec7b7918.pdf",
            "news_date": "2025-10-10 17:00:59"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "The intimation of closure of trading window for dealing in Securities of the Company by Designate Persons and their immediate relatives with effect from October 1 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6b3b9c72-15fd-4aa3-a689-6b18e4ae27ba.pdf",
            "news_date": "2025-09-25 17:36:10"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for reminding about Special Window for re-lodgement of Physical Share Transfer Requests",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ac294bd-c87c-4e9c-ac0e-29e85b8c452e.pdf",
            "news_date": "2025-09-17 19:43:01"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the details of Analyst/Institutional Investors meet which will be participated by the Company is attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fdbc18e4-6a2e-433c-acaa-7efb9dd21370.pdf",
            "news_date": "2025-09-01 19:38:13"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding 100 Days Campaign - \"Saksham Niveshak\"",
            "news_body": "Intimation regarding 100 Days Campaign - \"Saksham Niveshak\"",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=82d448f6-17fc-4ab4-8ebc-8529edc19629.pdf",
            "news_date": "2025-08-20 22:25:50"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the details of Institutional Investors meet which will be participated by the Company is attached.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c04480e2-2d4d-4136-84cc-c27bf5863f1a.pdf",
            "news_date": "2025-08-18 17:35:23"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper publication for Financial Result for Quarter ended June 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ba02f33-e7b5-4d6f-9cea-4e370134e5db.pdf",
            "news_date": "2025-07-26 16:16:06"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Amendment In Policy Of The Company",
            "news_body": "The Board at its meeting held on July 25 2025 has approved amendment to the Policy for Determination of Materiality of Events.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f523945-a72f-4013-b716-f3b605ece0ba.pdf",
            "news_date": "2025-07-25 20:13:02"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for quarter ended on June 2025",
            "news_id": "1371a318-5ab2-4944-8e22-405fd0612f6a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe61fba0-e96e-409d-a10b-8198353f80e5.pdf",
            "news_date": "2025-07-25 20:04:17",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation for quarter ended on June 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe61fba0-e96e-409d-a10b-8198353f80e5.pdf",
            "news_date": "2025-07-25 20:04:17"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Pursuant to Regulation 30 of the SEBI LODR 2015 we wish to inform you that on the recommendation of NRC committee and Board approved appointment of Mr. Deepak Shukla as Chief Executive -API Business in capacity of SMP wef from July 28 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ac50d30-cd4c-4d66-81a5-6a09456a36f2.pdf",
            "news_date": "2025-07-25 20:01:11"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b46e014a-34bc-4a23-93cb-339398a86924.pdf",
            "news_date": "2025-07-25 19:43:39"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited financial result for the quarter ended on June 30 2025",
            "news_id": "66a6f0ca-a697-4670-ae1c-3dc1194fb852",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d653033-6ed1-40a4-957f-7e772121ce8a.pdf",
            "news_date": "2025-07-25 19:30:47",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended On June 30 2025",
            "news_body": "Unaudited financial result for the quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7d653033-6ed1-40a4-957f-7e772121ce8a.pdf",
            "news_date": "2025-07-25 19:30:47"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25 2025",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and\r\nDisclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the\r\nCompany at its meeting held on Friday July 25 2025 inter-alia considered and unanimously approved\r\nthe following agenda items:\r\n1. Unaudited Financial Results:\r\nThe Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon\r\nare enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing\r\nObligations and Disclosure Requirements) Regulations 2015.\r\n2. Revision in the Policy for Determination of Materiality of Events:\r\nRevision in the policy for Determination of Materiality of Events in accordance with the amended SEBI\r\n(Listing Obligations and Disclosure Requirements) 2015. The aforesaid amended policy shall be made\r\navailable on the Companys website at www.rpglifesciences.com_policies",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a27c154-80a6-42c2-9514-58c30f232e99.pdf",
            "news_date": "2025-07-25 19:15:04"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Board Meeting Intimation To Consider And Approve Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 inter alia to consider and approve Board Meeting Intimation to Consider and Approve Unaudited Financial Results for the quarter Ended June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bda3bd2a-917c-4c11-a6ec-e1e500e624dd.pdf",
            "news_date": "2025-07-18 20:58:03"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper notice of Special Window for Re-lodgment of Physical Shares Transfer of Requests",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb696744-88af-4a08-84eb-cb11b2cd89c2.pdf",
            "news_date": "2025-07-18 20:51:35"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Voting Result Of 18Th Annual General Meeting",
            "news_body": "Details of Voting Result and Brief Proceedings of 18th Annual General Meeting of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0fe64a64-9f7b-44ff-bf15-ea713a26ab3c.pdf",
            "news_date": "2025-07-16 21:48:02"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Brief of Proceedings Voting result and Scrutinizer Report for 18th Annual General Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb2b29c8-066f-40c0-90d2-9b89d7bf692a.pdf",
            "news_date": "2025-07-16 20:27:24"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Brief Proceedings and details of voting results of 18th Annual General Meeting of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=599a9900-a139-429d-8d12-5cac413a01fa.pdf",
            "news_date": "2025-07-16 20:13:25"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are enclosing herewith certificate dated July 4 2025 issued by MUFG Intime India Private Limited Registrar and Transfer Agents confirming compliance under regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cde60c4a-5aad-4ca5-b518-059aa13a7d74.pdf",
            "news_date": "2025-07-14 12:56:51"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that pursuant to the code of fair disclosure internal procedures and conduct for regulating monitoring and reporting of trading by insiders of the company and SEBI (PIT) regulation 2015 the trading window for dealing in securities of the company by designated persons and immediate relatives shall remain closed from Tuesday 1 2025 until 48hrs after the declaration of unaudited financial result for the quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ad75b015-16f2-4f8c-8bb9-b07c7d10422f.pdf",
            "news_date": "2025-06-25 19:46:13"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": " Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company",
            "news_body": "Pursuant to Regulation 36(1) (b) of the SEBI LODR 2015 the company has sent the letter to those Members whose email addresses are not registered with Company/MUFG Intime India Private Limited (RTA) /NSDL and or CDSL stating the weblink where the Annual report is uploaded on website.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0850108c-9236-428d-b383-772d3a69cced.pdf",
            "news_date": "2025-06-24 18:35:37"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015 we enclosed herewith the copy of Notice 18th AGM published in todays newspaper in Business Standard (English) and Mumbai-Lakshadeep (Marathi) as intimation of completion of dispatch of Notice of AGM and information related E-voting.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65f25134-d878-4e17-8fbe-67dae7a33f94.pdf",
            "news_date": "2025-06-24 18:28:20"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "This is further to our letter dated June 14 2025 conveying that the 18th AGM of the Company is Scheduled on Wednesday 16 2025 through VC/OAVM mode. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (LODR) Regulation 2015 we are hereby submitting the Annual Report along with BRSR report for the financial year 2024-25.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38911cb3-55a9-4fa9-9422-342b516b09be.pdf",
            "news_date": "2025-06-23 13:56:06"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "This is further to our letter dated June 14 2025 conveying 18th AGM of the Company is Scheduled on Wednesday July 16 2025 Through VC/OAVM mode. Pursuant to Regulation 34(1) and Regulation 30(2) of SEBI (LODR) Regulation 2015 we are herewith submitting the Annual Report of the Company for the Financial year 2024-25.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34464791-ac66-4d0e-8a8f-60419591c335.pdf",
            "news_date": "2025-06-23 13:39:04"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 18Th Annual General Meeting Scheduled On Wednesday July 16 2025.",
            "news_body": "The letter in further to our letter dated June 14 2025 conveying that 18th Annual General Meeting of the Members of the company will be held on Wednesday July 16 2025 at 3:00 p.m. through Video Conferencing (VC)/ other Audio-Visual Means (OAVM).",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49cf3554-dd21-4a80-ab5f-cff6fbf7bb2c.pdf",
            "news_date": "2025-06-23 13:20:50"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "RPG Life Sciences Limited has informed the Company about the Newspaper advertisement regarding Record date of 18th AGM",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b37b4261-d236-4824-a545-b66462379623.pdf",
            "news_date": "2025-06-16 18:03:19"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date For 18Th AGM Of The Company Scheduled On July 16 2025.\r\n",
            "news_body": "The Board of Directors at its meeting scheduled on April 28 2025 had recommended a final dividend of Rs. 20 and additionally a special dividend of Rs.4 aggregating to Rs. 24 per  Equity shares of Rs.8 each of the Company for 18th AGM Scheduled on July 16 2025 fixed the record Friday 27 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d58b266-b556-45e8-8bde-3104a4b05f86.pdf",
            "news_date": "2025-06-14 15:57:16"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": " Email Communication To Shareholders Regarding Dividend Taxation Provisions",
            "news_body": "Email Communication to shareholders regarding Dividend taxation provisions",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b2cfff8b-4658-4ef9-8ffe-ae4891dec7d2.pdf",
            "news_date": "2025-06-05 20:30:21"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Further To Our Letter Dated April 28 2025 We Enclose Herewith Updated Annexure C Pursuant To Details Required As Per SEBI Circular No. SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 132023.",
            "news_body": "Update in Announcement filed on April 28 2025 board meeting outcome.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e952869-4970-47ad-83fc-d87d1253ec5e.pdf",
            "news_date": "2025-06-03 21:58:01"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation To Shareholders Holding Shares In Physical Mode Regarding Furnishing Of PAN KYC Details And Nomination",
            "news_body": "Pursuant to Regulation 30 of SEBI LODR 2015 as amended please find enclosed letter copy dispatched to shareholders holding shares in physical mode in compliance of SEBI Master circular no. SEBI/HO/MIRSD/POD-1/P/CIR/2024/37 dated May 7 2024. The physical shareholders are requested to furnish their PAN KYC and nomination details for updation to RTA.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c9b1b3e-ad3b-4125-b86b-6138d3113c78.pdf",
            "news_date": "2025-06-03 21:49:40"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of letter May 29 2025 and pursuant to regulation 30 of SEBI LODR 2015 the investor presentation which will be made during the RPG Investor conference 2025 scheduled on June 3 2025.",
            "news_id": "3a470c5a-d000-47ef-96a7-4924673e281e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c2d7fe-cf03-4f5c-b358-cb15d0d163ba.pdf",
            "news_date": "2025-06-02 20:15:23",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of letter May 29 2025 and pursuant to regulation 30 of SEBI LODR 2015 the investor presentation which will be made during the RPG Investor conference 2025 scheduled on June 3 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57c2d7fe-cf03-4f5c-b358-cb15d0d163ba.pdf",
            "news_date": "2025-06-02 20:15:23"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "In Accordance With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (\"Listing Regulations\") To Shareholders Whose Shares Are Liable To Be Transferred To IEPF Authority.",
            "news_body": "Intimation letter to shareholders  transfer of shares to IEPF Authority pursuant to transfer to IEPF",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=de7eaa79-4964-4f03-b0c8-83e544a75eeb.pdf",
            "news_date": "2025-06-01 15:50:08"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to 30 (6) read with para A of schedule III of SEBI LODR 2015 for please find below the details of the Analyst/ Institutional investor meet to be attended by the Company are given below:\r\n\r\nRPG Annual Investor Conference 2025 on June 3 2025 at 8 a.m. onwards in person at Mumbai.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=008d8b35-12f0-46f6-87f0-8f7d5795fa5d.pdf",
            "news_date": "2025-05-29 19:39:36"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Compliance",
            "descriptor": "Reg.24(A)-Annual Secretarial Compliance",
            "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
            "news_body": "Annual Secretarial compliance report for year ended on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37be8eb4-b9e5-4e0f-a266-ed9edd9413d3.pdf",
            "news_date": "2025-05-23 19:16:44"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of transcript of Results Earning Calls for Audited Financial Results for the Quarter ended on March 31 2025 held on Tuesday 29th April 2025.",
            "news_id": "d0e1f896-061f-491c-9067-8e3ccf7fb723",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a291a883-83d5-4759-b606-f11e746410f0.pdf",
            "news_date": "2025-05-05 18:29:00",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Intimation of transcript of Results Earning Calls for Audited Financial Results for the Quarter ended on March 31 2025 held on Tuesday 29th April 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a291a883-83d5-4759-b606-f11e746410f0.pdf",
            "news_date": "2025-05-05 18:29:00"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "Earning Call Audio Recording Link For Q$ Ended On March 31 2025.",
            "news_body": "Intimation of audio call recording of the results earning calls for audited financial result for quarter and FY ended on March 31 2025 held today i.e. Tuesday April 29 2025.",
            "news_id": "beac9e10-36e7-4065-8ab9-b89586dc8677",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd4bb53-b211-4c19-9212-803160783b9b.pdf",
            "news_date": "2025-04-29 19:34:52",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Earning Call Audio Recording Link For Q$ Ended On March 31 2025.",
            "news_body": "Intimation of audio call recording of the results earning calls for audited financial result for quarter and FY ended on March 31 2025 held today i.e. Tuesday April 29 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4cd4bb53-b211-4c19-9212-803160783b9b.pdf",
            "news_date": "2025-04-29 19:34:52"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "In terms of the regulation 30 read with schedule III of SEBI LODR 2015. please find enclosed herewith a copy of the newspaper publications with respect to audited financial result for the quarter ended on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36c360f4-7397-4c12-8483-61bd760e76f7.pdf",
            "news_date": "2025-04-29 19:12:04"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for earning calls for quarter ended on March 31 2025.",
            "news_id": "8ae6a218-5505-491d-a7fe-653eee612b16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21a0ec4a-d895-44a4-b20c-108859d5a5d4.pdf",
            "news_date": "2025-04-29 12:27:47",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for earning calls for quarter ended on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=21a0ec4a-d895-44a4-b20c-108859d5a5d4.pdf",
            "news_date": "2025-04-29 12:27:47"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Amendment Of Policies",
            "news_body": "Amendment of Policies",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38cd9d70-02fa-462d-a7ee-1c61a7510f18.pdf",
            "news_date": "2025-04-28 23:59:54"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under 30(5) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015",
            "news_body": "Intimation under regulation 30(5) of SEBI LODR",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3039f4e8-05a1-4901-b3cc-0a10f527581c.pdf",
            "news_date": "2025-04-28 22:41:29"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for quarter and financial year ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38e8f858-693d-4886-94ff-b27a5978c323.pdf",
            "news_date": "2025-04-28 22:21:59"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Final dividend approved in board meeting held on April 28 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7417bafe-4fdf-4140-9d8b-7c4ce6b0f7f4.pdf",
            "news_date": "2025-04-28 22:17:33"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Secretarial Auditor For Term Of Five (5) Years",
            "news_body": "Appointment of Secretarial Auditor for term of Five (5) years",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb3cc542-efc1-4c0e-9c10-3a2c54537c7e.pdf",
            "news_date": "2025-04-28 21:58:02"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Directorate",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Directorate",
            "news_body": "Change in Directorate as on April 28 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d146df0-ab91-4dcc-be18-ae9e3eb9da88.pdf",
            "news_date": "2025-04-28 21:42:38"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Financial Result for quarter and year ended on March 2025",
            "news_id": "6fd3260b-f375-4cf2-add8-cac893548b00",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53aeab0-10c4-4eea-8227-e73b9b7732b2.pdf",
            "news_date": "2025-04-28 21:24:34",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Financial Result for quarter and year ended on March 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d53aeab0-10c4-4eea-8227-e73b9b7732b2.pdf",
            "news_date": "2025-04-28 21:24:34"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Audited Financial Result For Quarter And Year Ended On March 31 2025",
            "news_body": "Audited Financial Result for the Quarter and year ended on March 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ecd922a-9737-47fc-93a1-48a50f5fd3c9.pdf",
            "news_date": "2025-04-28 21:10:56"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Results Earnings Call for audited Financial Results of the Company for the quarter and half year ended Mar 31 2025 will be held on Tuesday April 29 2025 at 3.30 p.m. IST. \r\nPlease find below the dial-in-details for the said call.\r\nDial-in Details:\r\nIndian (Universal) and Mumbai +91 22 6280 1116 \r\n+91 22 7115 8017\r\nLocation Toll Free Number\r\nUS 18667462133\r\nUK 08081011573\r\nSingapore 8001012045\r\nHong Kong 800964448\r\nDiamond Pass Link Link to register- https://tinyurl.com/f62v7vrw \r\n\r\nThe investor presentation shall be shared with the Exchanges separately.\r\nYou are requested to kindly take the same on record and disseminate appropriately.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44989efb-c5c4-4023-a3e3-adef95121d7e.pdf",
            "news_date": "2025-04-23 17:47:58"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI LODR 2015 This Is To Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled On Monday April 28 2025",
            "news_body": "RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 inter alia to consider and approve Pursuant to regulation 29 of the SEBI LODR 2015 this is to inform you that a meeting of the board of directors of the company is scheduled on Monday April 28 2025 inter alia to-\r\n 1. Consider and approve the Audited Financial Results for the quarter and financial year ended March 31 2025.\r\n2. Recommend dividend if any on Equity Shares of the Company for the financial year ended March 31 2025\r\nFurther pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from April 1 2025 and will continue to remain closed till 48 hours after declaration of results on April 28 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b72056c-4e91-4ef6-a59e-33b3fdf3aacc.pdf",
            "news_date": "2025-04-21 17:51:37"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Compliance",
            "descriptor": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure ",
            "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
            "news_body": "  <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>RPG Life Sciences Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24232MH2007PLC169354</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>A+</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>ICRA LIMITED</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table>  <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Rajesh Shirambekar <br/>  Designation: Company Secretary <br/> EmailId: rajesh.shirambekar@rpgls.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Vishal Shah <br/> Designation: Chief Financial officer <br/> EmailId: vishal.shah@rpgls.com</div> </div> <div> <br/> Date: 19/04/2025<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0d4780a6-8a7c-4c9c-b0ef-85d81f97a59a.pdf",
            "news_date": "2025-04-19 12:54:14"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are enclosing herewith certificate dated April 03 2025 issued by MUFG Intime India Private Limited Registrar and Transfer Agents confirming compliance under Regulation 74(5)  of SEBI (Depositories and Participants) Regulations 2018.\r\n\r\nKindly take the same on record.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a40323c6-2466-417a-bb6b-fee1357ca483.pdf",
            "news_date": "2025-04-11 13:53:12"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirement) Regulations 2015 we wish to inform you that on the recommendation of the Nomination and Remuneration Committee the Board of Directors on April 7 2025 has approved appointment of Ms Sheetal Gaba as Chief Human Resource Officer (CHRO) in capacity of a Senior Management Personnel of the Company w.e.f April 7 2025.\r\n",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02a7fce0-4e5c-438a-b3b2-53ba85971b34.pdf",
            "news_date": "2025-04-08 11:07:16"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "This is to inform you that pursuant to Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and SEBI (Prohibition of Insiders Trading) Regulation 2015 the Trading window for dealing in securities of the company by Designated Persons and their immediate relatives shall remain Closed from Tuesday April 1 2025 until 48 hours after the declaration of audited financial results by the Company for the year ending on March 31 2025.\r\nThe date of Board Meeting of the Company for consideration and declaration of audited financial results for the year ending on March 31 2025 will be intimated in due course",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e3cf3196-7d13-4d45-b85c-42a3c6b9ff0e.pdf",
            "news_date": "2025-03-25 18:05:09"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.",
            "news_body": "Pursuant to Regulation 30 read with Para A of Part A of Schedule  III of SEBI (Listing Obligations and Disclosure Requirement  regulation 2015 and securities and exchange board of India (listing obligations and disclosure requirements) (Third Amendment) Regulations 2024 dated December 13 2024 we wish to inform you that the company has received an order from Assessment unit  Income Tax Department and details are enclosed as per SEBI Circular no SEBI/HO/CFD-PoD-1/P/CIR/2023/123 dated July 13  2023 in Annexure Ato this disclosure",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5e2bde58-36e2-4db7-b75b-881bfdc52112.pdf",
            "news_date": "2025-03-21 13:55:06"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 read with Para A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the details of Institutional Investors meet which will be participated by the Company for which details as attached.\r\n\r\nKindly take the above on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=17b5bff8-a594-4da7-8739-91d5fc9ea33c.pdf",
            "news_date": "2025-02-25 18:24:21"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Update On Transfer Of Surplus Vacant Leasehold Land",
            "news_body": "We wish to inform you that further to our intimation dated September 13 2024  along with the disclosures made therein the Company has today executed the Deed of assignment cum Sale to assign and transfer the surplus vacant leasehold land along with built up structures situated at plot no. 25/25A-2 M.I.D.C land Thane-Belapur Road Navi Mumbai 400703 Maharashtra thereby fully consummating the transaction.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56af6f1b-5596-46c2-8008-d6da5971e31b.pdf",
            "news_date": "2025-02-13 17:06:51"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations\r\nAnd Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of SEBI LODR 2015 for details of order received from GST Authority Lucknow Uttar Pradesh.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f803a72f-d6d2-4a35-bb35-451d58f0f808.pdf",
            "news_date": "2025-02-07 16:30:23"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended December 31 2024.",
            "news_id": "d0676139-c4e3-48ce-88d5-74088fc322a3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f376eacc-ae43-4469-aba8-94e97241ed6b.pdf",
            "news_date": "2025-01-28 18:12:08",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f376eacc-ae43-4469-aba8-94e97241ed6b.pdf",
            "news_date": "2025-01-28 18:12:08"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find enclosed herewith copy of newspaper publication with respect to the Unaudited Financial Results for the quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4854e76-a4d5-4226-95ff-79585d41c780.pdf",
            "news_date": "2025-01-25 14:13:14"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find enclosed herewith a copy of press release with respect to Unaudited Financial Results of the Company for the quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fb1269f-56a6-41c1-8df9-d188da65b740.pdf",
            "news_date": "2025-01-24 20:21:29"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Code of Conduct under SEBI (PIT) Regulations 2015",
            "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
            "news_body": "The Company has informed Exchange regarding Board approval for revision in the Code of Conduct under SEBI (PIT) Regulations 2015.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=963fd155-d480-40b1-8201-285641f27531.pdf",
            "news_date": "2025-01-24 19:58:19"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Integrated Filing (Financial)",
            "caption": "Integrated Filing (Financial)",
            "news_body": "Pursuant to SEBI Circular dated December 31 2024 read with BSE Circular and NSE Circular dated January 2 2025 we are submitting herewith the Integrated Filing (Financial) for the quarter ended December 31 2024.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=547df6ce-c2c7-491a-b467-319f7497a418.pdf",
            "news_date": "2025-01-24 19:51:58"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the period ended December 31 2024 are enclosed.",
            "news_id": "9a7169a0-58dc-4725-869a-b7c1100952e4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ed23fab-b982-4b54-8c51-c8368059941c.pdf",
            "news_date": "2025-01-24 19:26:49",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Unaudited Financial Results For The Period Ended December 31 2024",
            "news_body": "Unaudited Financial Results for the period ended December 31 2024 are enclosed.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ed23fab-b982-4b54-8c51-c8368059941c.pdf",
            "news_date": "2025-01-24 19:26:49"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Of The Company Held On January 24 2025",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors of the Company has at its meeting held on Friday January 24 2025 inter-alia considered and approved the 1. Unaudited Financial Results of the Company for the quarter ended December 31 2024 and Intimation about change in Code/Policy.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49699ad7-29ae-4342-b6fc-4e9096783d66.pdf",
            "news_date": "2025-01-24 19:19:06"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of The Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "RPG LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve Pursuant to the provisions of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled on Friday January 24 2025 inter-alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2024.\r\n \r\nFurther pursuant to the Code of Fair Disclosure Internal Procedures and Conduct for Regulating Monitoring and Reporting of Trading by Insiders of the Company and the SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in Securities of the Company by Designated Persons and their immediate relatives is closed from January 1 2025 and will continue to remain closed till 48 hours after the results are made public on January 24 2025.\r\n\r\nKindly take this information on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed4a1ee1-e262-47c0-8681-8aa3360d611d.pdf",
            "news_date": "2025-01-17 17:47:51"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "We are enclosing herewith certificate dated January 6 2025 issued by MUFG Intime India Pvt. Ltd. Registrar and Transfer Agents confirming compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018.\n\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e18cfbbc-f3b8-4e9a-9391-d1e30262ea2e.pdf",
            "news_date": "2025-01-08 12:11:21"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Incidence Of Fire At The Manufacturing Plant Located At Navi Mumbai.",
            "news_body": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 we hereby inform you that an incidence of fire occurred on January 2 2025 at around 21.00 hours at one of the manufacturing blocks situated at Plot No. 25/25A M.I.D.C. Land Thane Belapur Road Navi Mumbai- 400703 Maharashtra.\n\nWe wish to inform you that there was no casualty or loss of human life in the incidence.\n\nCurrently the Company is in the process of investigating the cause and evaluating the extent of damage caused. The Company has adequate insurance coverage for assets in the said plant.\n\nThe details required under SEBI Circular dated July 13 2023 are provided in the announcement.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=134478e2-5099-4143-b36a-10bfae219f4e.pdf",
            "news_date": "2025-01-03 17:54:33"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Please find enclosed herewith intimation of loss of shre certificate as received by us from Link intime India Private Limited our RTA being submitted to you pursuant to Regulation 39(3) of the SEBI (LODR) Regulations 2015.\n\nKindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bd09b660-3266-455c-86a1-a501a02410f0.pdf",
            "news_date": "2024-12-27 16:42:29"
        },
        {
            "co_code": 29175,
            "bse_code": 532983,
            "isin": "INE105J01010",
            "ann_type": "",
            "descriptor": "Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "caption": "Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate",
            "news_body": "Please find enclosed herewith intimation of loss of share certificate as received by us from Link Intime India Pvt. Ltd. our RTA, being submitted to you pursuant to Regulation 39(3) of SEBI (LODR) Regulation, 2015.Kindly take the same on record.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69d4d3ee-113a-4f6f-8029-ebf0d9460bba.pdf",
            "news_date": "2024-12-16 12:28:54"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "The Transcript for the Results Earnings Call for Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024 is made available on the website of the Company.",
            "news_id": "68a5a806-0000-41f1-b4a7-3e35f79c7fa5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f61bc910-efbc-43a9-bdd4-a5e46fdb263b.pdf",
            "news_date": "2024-11-12 19:01:39",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "We hereby submit the weblink of audio recording of the Results Earning Call for Unaudited Financial Results of the Company for quarter and half year ended September 30, 2024",
            "news_id": "6885d0af-8a9a-46b1-9480-2976b2e2c085",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=df991d3f-be69-4859-9c5d-ae5cd30bd229.pdf",
            "news_date": "2024-11-08 21:58:22",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2024.",
            "news_id": "8b68c1ce-c0d7-471f-b018-6f7611e5a38e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2e112c0-3803-4f32-90f5-0bbd490631a1.pdf",
            "news_date": "2024-11-08 11:26:39",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For Quarter And Half Year Ended September 30, 2024",
            "news_body": "As per SEBI (LODR), please find attached herewith the UFR of the Company for the quarter and half year ended September 30, 2024",
            "news_id": "695a052c-2606-4a71-a3ed-e220fbc0fbaf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaad3172-b069-4059-8ef7-8467de0489da.pdf",
            "news_date": "2024-11-07 18:06:21",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The Company has submitted the audio recording for the conference call for Investor/ Analyst Meeting held today.",
            "news_id": "70da20e2-404e-4ecd-b790-856f8af577ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f5760d9-e479-40ac-9b8a-2dec8ee3d46e.pdf",
            "news_date": "2024-09-18 19:15:38",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to the Unaudited Financial Results of the Company for the quarter ended June 30, 2024",
            "news_id": "5546d7f6-d030-4c91-a340-e26502a6640e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b871eab2-5f0d-49e7-8bd6-38d315753222.pdf",
            "news_date": "2024-07-27 15:57:55",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2024",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2024 approved and taken on record by the Board at its meeting held on July 19, 2024 along with limited Review Report signed by the Statutory Auditors of the Company",
            "news_id": "28f5c604-09b9-4cb1-9db6-446e1a7fef35",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3b031e64-3770-4194-b167-7f2de631ab29.pdf",
            "news_date": "2024-07-19 17:57:43",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Company has informed about Investor Presentation",
            "news_id": "c3bcb3ec-e1ea-4220-a014-64a5f7f78c1b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9351c4d6-b785-4f3c-9595-5236dd084131.pdf",
            "news_date": "2024-06-06 20:08:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation to our Letters dated April 26, 2024, May 01, 2024 and May 02, 2024, the transcript of the Results Earnings call for the Audited Financial Results for the quarter and year ended March 31, 2024 held on May 02, 2024 at 3.30 p.m. IST is made available on the Company''s website.",
            "news_id": "74587323-c81d-4017-8529-70a6f8b8afbf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c4840999-1371-49db-a133-3c69378135a9.pdf",
            "news_date": "2024-05-08 16:55:10",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "The Audio recording for the earnings call for Audited FInancial Results of the Company as on March 31, 2024 is attached.",
            "news_id": "90b11cf5-0be1-443d-844f-089e084bbf5c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=64265712-b2ba-413d-a9cd-5aa8cf9ba131.pdf",
            "news_date": "2024-05-02 19:58:56",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Audited Financial Results of the Company for the quarter and year ended March 31, 2024.",
            "news_id": "d4b7a9f9-6ea1-49e4-9d72-dc531f79d143",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=448d6df6-a720-499e-82c7-6cfe76bf321b.pdf",
            "news_date": "2024-05-01 22:32:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Of The Company Held On April 30, 2024",
            "news_body": "Audited financial Results for quarter and year ended March 31, 2024.",
            "news_id": "f24c49df-da94-45df-9177-91f06de1d41e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d68a234-5f2c-4cf1-980e-7f85ba067a2a.pdf",
            "news_date": "2024-04-30 19:51:03",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2023.Kindly take the same on record.",
            "news_id": "5cbeb72f-0eef-495d-b6f8-1dd3562b6234",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7335c6fe-b0de-4236-8056-7a37f026d291.pdf",
            "news_date": "2024-02-02 17:11:45",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "RPG Life Sciences Limited has informed exchanges regarding Financial results for Quarter and Nine Months ended on December 31, 2023.Kindly take the same on record.",
            "news_id": "8285fa6a-54c9-459d-910f-f82845bb2141",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4858060-17ad-4390-ae36-afcc291f2a9d.pdf",
            "news_date": "2024-02-01 17:49:53",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated October 13, 2023 and October 19, 2023, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2023, held on Thursday, October 19, 2023, at 3.30 p.m. IST. has been made available on the Company''s website.Kindly take the same on record.",
            "news_id": "253f7930-f901-48d7-b78f-6134e8cca567",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ef73901-38ca-4a78-9917-f893d2ae51d1.pdf",
            "news_date": "2023-10-25 18:22:09",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation to our Letters dated October 13, 2023 and October 19, 2023, we would like to inform you that the audio recording of the Results Earnings Call for the Unaudited FInancial Results for the quarter and half year ended September 30, 2023, held today, Thursday, October 19, 2023 at 3.30 p.m. IST has been made available on the websie of the company.Kindly take the same on record.",
            "news_id": "bf05e7ee-74a6-48fd-a268-c0a7b1a4ea39",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8ad4701a-8de5-4e67-843d-36ae0967f1d5.pdf",
            "news_date": "2023-10-19 19:16:48",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of investor presentation with respect to the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2023.Kindly take the same on record.",
            "news_id": "f99c9b58-8b9e-412f-b572-82490871925f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55744826-2434-49b7-91fd-a6bb060bb964.pdf",
            "news_date": "2023-10-19 14:56:38",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "RPG Life Sciences Limited has informed the exchanges regarding Financial results for quarter and half year ended September 30, 2023.",
            "news_id": "8220126a-f106-4b6b-8f89-2a5863355deb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4275f921-60b1-4fac-b8bf-a84d00e8b2da.pdf",
            "news_date": "2023-10-18 18:23:52",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of investor presentation with respect to the Unaudited Financial Results of the Company for the quarter ended June 30, 2023",
            "news_id": "67728945-6a3c-4f98-8992-f0e13e641dce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e45abb8-d959-4d2c-bf11-a4bf23fafd03.pdf",
            "news_date": "2023-07-29 16:19:56",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2023",
            "news_body": "Unaudited Financial Results for the quarter ended June 30, 2023 approved and taken on record by the Board of Directors at its meeting held on July 28, 2023 along with the Limited Review Report issued by the Statutory auditors of the Company.<BR> <BR> The meeting commenced at 03.00 p.m. and concluded at 05.30 p.m.<BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "a190f170-db66-4b55-b42f-a5bd81fa368f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b004d3a3-a935-4444-8a01-088ec1aac7d7.pdf",
            "news_date": "2023-07-28 17:58:09",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated April 25, 2023  and May 2, 2023, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2023, held on Tuesday, May 2, 2023, at 3.30 p.m. IST. has been made available on the Company's website at:  https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "ea4f449d-508c-4c7c-9a77-9b4c952cfe29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbd82909-206a-4d47-bf7c-fb5ba3608703.pdf",
            "news_date": "2023-05-08 10:39:20",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "n continuation of our Letters dated April 29, 2023 and May 02, 2023, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the year ended March 31, 2023, held today i.e. Tuesday, May 2, 2023, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "a26cbdc7-1e7b-4466-a12f-220a0373fafa",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=693847c8-656b-4570-8efe-98aab9a15d62.pdf",
            "news_date": "2023-05-02 20:34:06",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our Letter dated April 25, 2023, please find enclosed herewith Investor Presentation for the quarter and year ended March 31, 2023, for the Results Earnings call scheduled on Tuesday, May 2, 2023, at 3.30 p.m. IST. Kindly take the same on record and disseminate appropriately.",
            "news_id": "a76dad12-fd09-4744-a8a7-95cc45038af5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da31a586-b142-4325-a1d0-964c29a46200.pdf",
            "news_date": "2023-05-02 13:30:46",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2023",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: <BR> <BR> 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion.<BR> <BR> 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.<BR> <BR> 3. Approved the Audited Financial Statements of the Company, for the year ended March 31, 2023.<BR> <BR> The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m.<BR> <BR> Kindly take the above on record.  <BR>",
            "news_id": "b0ec9180-0494-455d-a679-2c32036d0fa3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0738b9a1-53dd-43be-93a6-f541f76b2034.pdf",
            "news_date": "2023-04-28 18:54:42",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On April 28, 2023",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. April 28, 2023, inter alia, has considered and unanimously: <BR> <BR> 1. Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2023. Copy of the same is enclosed along with the Report of the Auditors thereon and a declaration stating that the said report is with unmodified opinion.<BR> <BR> 2. Recommended equity dividend of Rs. 12 per share of Rs. 8/- each (150%) for the financial year ended March 31, 2023, which will be paid to the shareholders within 30 days of declaration of the same at the ensuing Annual General Meeting.<BR> <BR> 3. Approved the Audited Financial Statements of the Company, for the year ended  March 31, 2023.<BR> <BR> The Board meeting commenced at 3:00 p.m. and concluded at 6.35 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "4ff0a12a-66f1-4e01-be52-bec893cb2679",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=954fe354-58f8-4361-8a91-f73b83c0fd10.pdf",
            "news_date": "2023-04-28 18:50:59",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. Kindly take the same on record.",
            "news_id": "d0f1cbc5-78c9-40a0-a48e-86deab7956b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=525450c2-6566-430c-83ea-1ac92d096023.pdf",
            "news_date": "2023-02-02 12:25:48",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, February 01, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022.  <BR> <BR> The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> The meeting commenced at 03:00 p.m. and concluded at 5.15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "74b06829-85cc-40b2-9056-bd61cd56fae4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40b93750-2b3a-468f-8e50-2aaecbe09747.pdf",
            "news_date": "2023-02-01 17:38:43",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for   Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2022",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has at its meeting held on Wednesday, February 01, 2023, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2022. <BR> <BR> The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 5.15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "2ce37391-f406-49c7-8b50-ff433e2ff515",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2f4a255-c345-4b20-874d-259a513c3869.pdf",
            "news_date": "2023-02-01 17:33:22",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended September 30, 2022. Kindly take the same on record.",
            "news_id": "31112fa8-92bb-4bac-8314-3cb8b605f003",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bb22f956-874d-468b-80d5-227b12a72d11.pdf",
            "news_date": "2022-10-31 14:17:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated October 11, 2022, October 17, 2022 and October 18, 2022, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2022, held on Tuesday, October 18, 2022, at 3.30 p.m. IST. has been made available on the Company's website at: https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "bc8eb64e-f84c-4429-a1d6-a8fce38871ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9bd87bd6-1ad6-47af-be06-0264f6e4b1ee.pdf",
            "news_date": "2022-10-21 21:34:39",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation of our Letters dated October 11, 2022 and October 17, 2022, we would like to inform you that audio recording of the Results Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2022, held today i.e. Tuesday, October 18, 2022, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "83cc9629-6ee4-4726-b17b-01a5cbdfb476",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6c33e64b-698f-4a46-a263-e4a3f881b772.pdf",
            "news_date": "2022-10-18 18:34:15",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our Letter dated October 11, 2022, please find enclosed herewith Investor Presentation for the quarter and half year ended September 30, 2022, for the Results Earnings Call scheduled on Tuesday, October 18, 2022, at 3.30 p.m. IST. Dial-in details of which are reproduced below for ready reference.Kindly take the same on record and disseminate appropriately.",
            "news_id": "4563d0d2-7a59-44ac-b2a1-b63193eda0ed",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=481b0f6b-f09a-40c9-aa2e-2f24fe2a1ce9.pdf",
            "news_date": "2022-10-17 20:09:25",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2022",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Monday, October 17, 2022, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 06:15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "6dba54dd-714b-41f7-abdb-335f66889e16",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b4cb704-0917-483d-aa74-b4fa3cce37d7.pdf",
            "news_date": "2022-10-17 18:43:16",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company has, at its meeting held on Monday, October 17, 2022, inter-alia, considered and approved the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. The said Unaudited Financial Results along with Limited Review Report of the Statutory Auditors thereon are enclosed herewith in terms of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 06:15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "1f9cdee1-06ce-46a9-a102-968c78af307d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf3fd384-4482-4337-880d-74a8ce993885.pdf",
            "news_date": "2022-10-17 18:38:55",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation to our Letter dated September 12, 2022, please find enclosed herewith the Investor's Presentation which will be made during RPG Annual Investor Conference 2022.Kindly take the same on record.",
            "news_id": "cfbd5226-05ee-4402-8c8e-d02865eaaec9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1258daac-eba7-49b9-ac8b-fae5f124b9a2.pdf",
            "news_date": "2022-09-13 18:52:54",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter ended June 30, 2022. Kindly take the same on record.",
            "news_id": "ffbdfaaa-e210-4918-b865-75cad21d96e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efac7750-bc9a-4bee-a245-aad97eb8ef0d.pdf",
            "news_date": "2022-08-04 20:25:11",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30, 2022",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2022 which were approved by the Board of Directors of the Company, at its meeting held on August 02, 2022 along with Limited Review  Report issued by the Statutory Auditors of the Company.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 06:00 p.m.<BR> <BR> Kindly take the above on your record.<BR>",
            "news_id": "f9732b72-a919-4d01-9950-f48ad3de82f4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1967151a-bb58-4ef4-a391-532c8ea4cca8.pdf",
            "news_date": "2022-08-02 18:17:06",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions.",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2022. Kindly take the same on record.",
            "news_id": "09d89f24-d3d8-42f4-a538-58acb0bee7d0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d074bd23-95b1-4141-80fe-0d674ef0526f.pdf",
            "news_date": "2022-05-11 18:01:24",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our Letters dated April 25, 2022, April 29, 2022, April 30, 2022 and May 2, 2022, we would like to inform you that transcript of the Results Earnings Call for the Audited Financial Results for the quarter and year ended March 31, 2022, held on Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company's website at:  https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "34c82624-6d57-40fc-829b-4ed2bed0f414",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e41bf79c-a756-4806-9108-5954290ee72a.pdf",
            "news_date": "2022-05-05 17:13:22",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation of our Letters dated April 25, 2022, April 29, 2022 and April 30, 2022, we would like to inform you that audio recording of the Results Earnings Call for the Audited Financial Results for the year ended March 31, 2022, held today i.e. Monday, May 2, 2022, at 3.30 p.m. IST. has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.phpKindly take the same on record and disseminate appropriately.",
            "news_id": "121a9170-e7c3-4cf0-852b-e30f70e13e67",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44970c71-bea6-4677-825e-71bbbd3d9d54.pdf",
            "news_date": "2022-05-02 19:13:51",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation of our Letters dated April 25, 2022 and April 29, 2022, please find enclosed herewith Investor Presentation for the quarter and year ended March 31, 2022, for the Results Earnings call scheduled on Monday, May 2, 2022, at 3.30 p.m. IST. Dial-in details of which are reproduced below for ready reference.",
            "news_id": "d048b23a-8202-43f2-aef2-5fbb251dedb0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8af5d09e-bde8-4361-9930-2dc8eeaba88f.pdf",
            "news_date": "2022-04-30 22:58:42",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2022",
            "news_body": "Audited Financial Results of RPG Life Sciences Limited, for the quarter and year ended March 31, 2022, approved and taken on record by the Board of Directors of RPG Life Sciences Limited at its meeting held on April 29, 2022 along with Auditors Report thereon with unmodified opinion.<BR> <BR> The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.",
            "news_id": "129a4107-e931-4e3f-88b7-4fb8d5cfe751",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b654768e-c84d-4528-af7d-441e4d8aeacc.pdf",
            "news_date": "2022-04-29 18:21:45",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for   Outcome Of The Board Meeting Held On April 29, 2022",
            "news_body": "Outcome of the meeting of the Board of Directors of RPG Life Sciences Limited held on April 29, 2022, in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> <BR> The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.",
            "news_id": "b302680e-712b-459d-9adf-61e064a44ec7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d3b564c5-7f82-43aa-98a1-6d1fdca3af16.pdf",
            "news_date": "2022-04-29 18:18:32",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find enclosed herewith a copy of Investor Presentation with respect to Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2021. Kindly take the same on record.",
            "news_id": "2f7d912c-7be8-474f-8d7b-94df57355044",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ecf5e01c-3b3f-468f-9fce-7803e6ab0929.pdf",
            "news_date": "2022-01-29 17:22:29",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Nine Months Ended December 31, 2021",
            "news_body": "Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and nine months ended December 31, 2021 which were approved by the Board of Directors of the Company, at its meeting held on January 25, 2022 along with Limited Review Report issued by the Statutory Auditors of the Company.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 05:15 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "f0aa8226-1c78-4b01-9e86-952400e142c2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa50dab7-7462-42b4-af4d-a703d585758a.pdf",
            "news_date": "2022-01-25 17:29:40",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "In continuation of our letters dated October 20, 2021, October 29, 2021 and November 1, 2021, we would like to inform you that transcript of the Results Earnings Call for the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021, held on Monday, November 1, 2021 at 4.00 p.m. IST has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.php. <BR> <BR> Kindly take the same on record and disseminate appropriately. <BR>",
            "news_id": "d5ed5aef-741c-4308-9cc5-d9eace400ed0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4636db0a-3861-4229-9f86-cd3d165dd31d.pdf",
            "news_date": "2021-11-08 20:28:27",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In continuation of our letters dated October 20, 2021 and October 29, 2021, we would like to inform you that audio recording of the Results Earnings Call for the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2021, held today i.e. on Monday, November 1, 2021 at 4.00 p.m. IST has been made available on the Company's website at https://www.rpglifesciences.com/website/earnings_call.php <BR> <BR> Kindly take the same on record and disseminate appropriately. <BR>",
            "news_id": "83361c2b-d07f-48bc-a8f0-bdb95950051e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e9a3134-0b82-4a74-8c3a-b421bd2a704e.pdf",
            "news_date": "2021-11-01 20:41:42",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investors Presentation for the quarter and half year ended September 30, 2021 and details of the Results earnings call.",
            "news_id": "0510c023-1343-43ad-a260-960951995d33",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=691e13cb-c1a2-4421-9604-cbb17fabe9d7.pdf",
            "news_date": "2021-10-29 19:59:09",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2021",
            "news_body": "Pursuant to Regulation 33 Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter and half year ended September 30, 2021 which were approved by the Board of Directors of the Company, at its meeting held on October 29, 2021 along with Limited Review Report issued by the Statutory Auditors of the Company. <BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 05:20 p.m.<BR> <BR> Kindly take the above on record.<BR>",
            "news_id": "d649c018-f1b1-476a-91a1-d46baf1b4931",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b84bc54b-3d11-4fa1-be16-f497f9aec985.pdf",
            "news_date": "2021-10-29 17:31:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Result For The Quarter Ended June 30, 2021",
            "news_body": "Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2021 which were approved by the Board of Directors of the Company, at its meeting held on July 28, 2021 along with Limited Review  Report issued by the Statutory Auditors of the Company.<BR> <BR> The meeting commenced at 03:00 p.m. and concluded at 05:00 p.m.<BR> <BR> Kindly take the above on your record.<BR>",
            "news_id": "f49c3cc6-e153-4ef5-8c32-3846529e5366",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36481263-9ee3-459d-b51d-438601151f76.pdf",
            "news_date": "2021-07-28 17:21:57",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In continuation to our letters dated June 9 and June 14, 2021, we would like to intimate that the recording of the Company's session at the RPG Annual Investor Conference 2021 has been voluntarily made available at the Investors section of the Company's website i.e. https://www.rpglifesciences.com/website/investor_presentations.php <BR> <BR> Kindly take the same on record.<BR>",
            "news_id": "998dba07-caf8-4668-b51c-4fc842bbd918",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=207bfc13-e8c6-4012-b912-9c8a61468d23.pdf",
            "news_date": "2021-06-26 10:34:26",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Half Yearly Disclosure On Related Party Transactions",
            "news_body": "In terms of Regulation 23(9) of the Securities and Exchange Board of India (Listing Regulations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosure of Related Party Transactions, in the format specified in the accounting standards for the half year ended March 31, 2021. <BR> Kindly take the same on record.<BR>",
            "news_id": "985402f4-c463-44c0-856e-85927e785871",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf2cccb8-83b1-40a0-b8a3-3c5b96257581.pdf",
            "news_date": "2021-05-25 18:11:05",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "RPGLIFE",
            "disp": "RPG Life Sciences",
            "bse_code": 532983,
            "isin": "INE105J01010",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Results For The Quarter And Year Ended March 31, 2021",
            "news_body": "Audited Financial Results of RPG Life Sciences Limited, for the quarter and year ended March 31, 2021, approved and taken on record by the Board of Directors of RPG Life Sciences Limited at its meeting held on April 30, 2021 along with Auditors Report thereon with unmodified opinion.<BR> <BR> The Board meeting commenced at 3.00 p.m. and concluded at 6.00 p.m.   <BR>",
            "news_id": "a6ea6df3-ff16-481f-9c8b-d64d5cc11f0e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=feef452d-2d72-4829-9ac2-2aee23759baa.pdf",
            "news_date": "2021-04-30 18:21:30",
            "seo": "rpg-life-sciences-ltd",
            "ltp": 2037.3,
            "ch": -34.399999999999864,
            "pch": -1.6604720760727842,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 16725,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}